المؤلفون: Kathleen Quigley, Roumen Balabanov, Richard K. Burt, Irene Helenowski, Xiaoqiang Han

المصدر: Journal of Neurology

مصطلحات موضوعية: medicine.medical_specialty, Neurology, Multiple Sclerosis, medicine.medical_treatment, Relapsing remitting multiple sclerosis (RRMS), Nonactive SPMS (naSPMS), Hematopoietic stem cell transplantation, Single Center, Gastroenterology, Hyperthyroidism, Transplantation, Autologous, Sepsis, Multiple Sclerosis, Relapsing-Remitting, immune system diseases, Internal medicine, Medicine, Humans, Progression-free survival, Original Communication, Secondary progressive multiple sclerosis (SPMS), business.industry, Multiple sclerosis, Hematopoietic Stem Cell Transplantation, Multiple Sclerosis, Chronic Progressive, medicine.disease, Active SPMS (aSPMS), Bacteremia, Disease Progression, Alemtuzumab, Hematopoietic stem cell transplantation (HSCT), Neurology (clinical), business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc261022336c16421eaadbeb3d365045
http://europepmc.org/articles/PMC8503710